SQA
VRTX icon

Simon Quick Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Simon Quick Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,933
Closed -$1.42M – 647
2025
Q1 		$1.42M Buy
2,933
+697
+31% +$325K 0.08% 111
2024
Q4 		$900K Buy
2,236
+24
+1% +$11.1K 0.05% 166
2024
Q3 		$1.03M Buy
2,212
+1,018
+85% +$489K 0.07% 149
2024
Q2 		$560K Sell
1,194
-194
-14% -$84.2K 0.04% 204
2024
Q1 		$580K Buy
1,388
+518
+60% +$219K 0.04% 181
2023
Q4 		$354K Buy
870
+31
+4% +$11.5K 0.03% 210
2023
Q3 		$292K Buy
839
+157
+23% +$54.9K 0.03% 241
2023
Q2 		$240K Buy
+682
New +$230K 0.02% 244
2020
Q4 		– Sell
-110
Closed -$30K – 555
2020
Q3 		$30K Sell
110
-9
-8% -$2.48K 0.01% 270
2020
Q2 		$35K Hold
119
– – 0.01% 239
2020
Q1 		$28K Buy
119
+29
+32% +$6.65K 0.01% 252
2019
Q4 		$20K Buy
90
+73
+429% +$14.8K 0.01% 326
2019
Q3 		$3K Buy
17
+13
+325% +$2.3K ﹤0.01% 336
2019
Q2 		$734 Buy
+4
New +$699 ﹤0.01% 437

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Simon Quick Advisors's VRTX Position: Q2 2025 in Review

Simon Quick Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 2,933 shares — an estimated $1.42M sold.

Simon Quick Advisors first reported a position in VRTX in Q2 2019 and held it in 14 quarters. The position peaked at $1.42M in Q1 2025. 1,562 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Simon Quick Advisors reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simon Quick Advisors sold 2,933 Vertex Pharmaceuticals shares in Q2 2025, an estimated $1.42M.
  • Simon Quick Advisors first reported a position in Vertex Pharmaceuticals in Q2 2019 and held it in 14 quarters.
  • Simon Quick Advisors's Vertex Pharmaceuticals position peaked at $1.42M in Q1 2025.
  • 1,562 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Simon Quick Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.